- The company’s strategic partnerships expand its product placement, while its white-labeling program captures additional market share
- ETST is committed to improving women’s health worldwide with the launch of Hygee
- The company continues to explore expansion of product placement, both online and in retail spaces
Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) operates in the fields of hemp cannabinoid, nutraceutical, pharmaceutical and medical device research and development. The company’s focus on strategic partnerships and becoming a global leader in the CBD sector, along with its commitment to bringing cutting-edge pharmaceutical and medical-device offerings to market, has put ETST in an intriguing position.
Strategic partnerships are key to ETST’s success. In February 2019, the company announced (http://cnw.fm/9jbGA) its entry into agreements with CannaBiz and Dessert Sun Distribution to provide high-grade, full-spectrum products to pharmacies, chiropractors, dispensaries, athletic clubs and clinics throughout the United States. The company has also created a way for other marketers to rebrand ETST’s full-spectrum cannabinoids line following countless white-labeling inquiries. By fulfilling these inquiries, the company is able to capture even more market share.
ETST is committed to bringing cutting-edge pharmaceutical and medical devices to market. Earth Science Pharmaceutical Inc., a wholly owned subsidiary of ETST, is focused on offering low-cost diagnostic tools, testing processes, medical devices and vaccines for women to detect and treat sexually transmitted illnesses.
The company’s first medical device to market is Hygee. Designed to detect STIs including chlamydia, Hygee is now ready for export, the company reports. Queen Concept Inc. has entered into a distribution agreement with ETST, making it the exclusive distributor of Hygee in Vietnam for the next five years. Nearly 7.5 million women in Vietnam fall within the demographic recommended for testing. Vietnam is the first of many countries that ETST is targeting.
Chlamydia is a global issue, with an estimated 130 million new cases diagnosed yearly. Diagnosing and treating chlamydia is particularly important for pregnant women, as the disease can be passed to the baby during childbirth. Following the launch of Hygee in Vietnam, marketing efforts will target North America, South America, Asia and Africa. Hygee packaging will feature English, French, Portuguese, Spanish, Vietnamese and Arabic in an effort to reach the 1.5 billion people who claim one of those languages as their mother tongue (http://cnw.fm/t5nIF). ETST is dedicated to revolutionizing women’s health worldwide.
Operating through four wholly owned subsidiaries, the company continues to explore expansion of product placement, both online and in retail spaces, as it develops a world leader role in the CBD space.
“I’m excited to share that our sales during the past three quarters have consistently increased over 100% every month,” ETST Chairman Nickolas S. Tabraue stated in a news release (http://cnw.fm/5w8Rr). “We have also received countless white-labeling inquires, and thanks to our reliable source and manufacturer, we are now able to fulfill these inquires and capture even more market share. We have a lot of opportunity on deck for 2019.”
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://cnw.fm/ETST
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
